Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial
Kehoe, Patrick Gavin, Turner, Nicholas, Howden, Beth, Jarutyte, Lina, Clegg, Shona Louise, Malone, Ian Brian, Barnes, Josephine, Nielsen, Casper, Sudre, Carole Hélène, Wilson, Aileen, Thai, Ngoc Jade, Blair, Peter Sinclair, Coulthard, Elizabeth, Lane, Janet Athene, Passmore, Peter, Taylor, Jodi, Mutsaerts, Henk-Jan, Thomas, David Lee, Fox, Nick Charles, Wilkinson, Ian, Ben-Shlomo, Yoav, Harkness, Kirsty, Kuruvilla, Tarun, McShane, Rupert, Connelly, Peter, Duncan, Gordon, Calvert, Lucy, Lawrie, Alasdair, Sheridan, Matthew, Jackson, Eric, Udeze, Bernard, Pearson, Stephen, Langheinrich, Tobias, Wagle, Suvarna, Butchart, Joseph, Macharouthu, Ajay, Donaldson, Andrew, Neil, Wendy, Pattan, Vivek, Findlay, David, Thomas, Alan, Barber, Robert, Byrne, Andrew, Dalvi, Madhusudan, Negi, Rashi, McGuinness, Bernadette
Published in Lancet neurology (01.11.2021)
Published in Lancet neurology (01.11.2021)
Get full text
Journal Article